Nvidia’s blowout guidance is reviving AI leadership, but ETF flows show investors are hedging that conviction with dividends, biotech, precious metals and cash flow. The second-half setup is not risk-on or risk-off; it is growth paired with policy protection today.
MLPs, energy infrastructure and cybersecurity led the latest theme tape, while blockchain, gold miners and crypto-linked ETFs lagged as investors weighed NVDA’s blowout guide against higher rates, oil uncertainty and Jackson Hole risk.
Biotech, blockchain, uranium/nuclear and semiconductors led the latest theme tape, while energy producers, cybersecurity and cloud software lagged ahead of NVDA earnings and Jackson Hole.
Thematic Pulse shows investors hedging inflation and geopolitical risk with dividend quality, gold and natural resources while trimming crowded AI hardware and generic software. Accumulation through weakness is strongest in grid, momentum, defense, biotech and chip vehicles ahead of Nvidia.
Insurance, travel/leisure, low-volatility and gaming led the latest theme tape, while China innovation, semiconductors, clean energy and robotics/AI lagged as momentum pressure persisted ahead of NVDA earnings and Jackson Hole.
Uranium, blockchain, copper miners and cannabis led the latest theme tape, while MLPs, hydrogen, infrastructure and semiconductors lagged as investors waited on Bessent’s Iran plan, NVDA earnings and Jackson Hole.
Real assets, free-cash-flow strategies and dividends currently lead thematic markets, but investors continue buying selected Growth exposure. Lower real yields could unlock the next rotation, favoring cloud, software and biotech rather than simply recreating the crowded semiconductor Momentum trade.
Crypto/blockchain and precious metals led the latest thematic tape, while biotech, aerospace/defense, clean energy and housing lagged as higher long-end rates and oil kept pressure on risk appetite.
Biotechnology is emerging as a new market leader as clinical breakthroughs, accelerating M&A and improving capital conditions drive ETF outperformance. AI is helping drug discovery, but the current rally is fundamentally rooted in clinical validation, pipeline value and industry consolidation.
Biotech and precious metals led the latest theme tape, while semiconductors, AI infrastructure, cybersecurity and China innovation lagged as momentum pressure continued to rotate through the AI hardware complex.
Stay updated with the latests analysis and insights from etfthemes.com